A Decade+ of Early Stage Process Chemistry at the Janssen Pharmaceutical Companies of Johnson & Johnson: Concepts and Applications
- 4/25/2014 |
3:00 PM – 4:00 PM
Location: Druckenmiller Hall, Room 020
Event Type: Seminar
Johnson & Johnson's Janssen unit is one of the largest pharmaceutical companies in the world. With products for a variety of diseases states (cancer, diabetes, arthritis, schizophrenia and many others), 2013 sales of $28.1 billion represented a nearly 11% increase from 2012. To maintain strong growth, Janssen has a strong commitment to Research & Development, including a Drug Discovery site in La Jolla, California. Over the last 14 years the La Jolla site has been at the vanguard in many Neuroscience and Immunology programs. The importance of early stage process chemistry support for these projects will be discussed. Specific examples from the H3 and FLAP projects will illustrate several critical general concepts.